Nabriva Therapeutics Plc
SEC CIK 1703287 · NBRV · last insider filing 2017-07-21
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bourdow Carrie L. | Director | filed 2017 - 2017 |
| Burgess Daniel D | Director | filed 2017 - 2017 |
| Corrigan Mark | Director | filed 2017 - 2017 |
| Broom Colin MD | Director · Chief Executive Officer | filed 2017 - 2017 |
| Rowland Charles A Jr | Director | filed 2017 - 2017 |
| Webster Stephen W | Director | filed 2017 - 2017 |
| Talbot George Harrison | Director | filed 2017 - 2017 |
| Khuong Chau Quang | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lavino Francesco Maria | Chief Commercial Officer | filed 2017 - 2017 |
| Crotty Robert | General Counsel & Corp Secreta | filed 2017 - 2017 |
| Sender Gary | Chief Financial Officer | filed 2017 - 2017 |
| Seltzer Elyse G. | Chief Medical Officer | filed 2017 - 2017 |
| Gelone Steven P. | Chief Development Officer | filed 2017 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.